CollPlant Biotechnologies Insider Trades
NASDAQ: OPHIHealth CareIndustrial SpecialtiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
CollPlant Biotechnologies insider activity
Over the last 12 months, CollPlant Biotechnologies insiders reported 2 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Rotem Eran (Deputy CEO and CFO) reporting a transaction in 510,372 shares on Sep 3, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put OPHI's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
OPHI insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 3, 2026 | Abelis Bar BertaVP Legal | Award | 201,141 | — | Form 4 |
| Sep 3, 2026 | Rotem EranDeputy CEO and CFO | Award | 510,372 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4